Serum Lipid Biomarkers and the Risk of Gastrointestinal Cancers in a Chinese Population: The Kailuan Prospective Study
Cancer Medicine · 2025
DOI: 10.1002/cam4.70654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Ying Xiao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing, China. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Lipids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Current evidence on relationships between serum lipid biomarkers and the risk of gastrointestinal cancers remains controversial, with no consensus reached.
Methods
We conducted a prospective cohort study within the Kailuan Cohort wherein 88,225 individuals with baseline information on triglyceride (TG), total cholesterol (TC), low‐density lipoprotein cholesterol (LDL‐C), and high‐density lipoprotein cholesterol (HDL‐C) was followed from 2006 to 2021 for the incidence of esophageal cancer (EC), gastric cancer (GC), and colorectal cancer (CRC). Cox proportional hazards models and restricted cubic spline (RCS) analysis were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
Results
Increased EC risk was associated with high HDL‐C levels (HR Q4vs.Q1 = 2.50, 95% CI: 1.57–3.98), while a U‐shaped relationship between HDL‐C and EC risk was revealed in the RCS analysis ( p overall ≤ 0.0001, p nonlinear = 0.02). No robust association was identified between lipid biomarkers and GC risk. In multivariable analysis, increased CRC risk was positively associated with high TC levels (HR Q4vs.Q1 = 1.42, 95% CI: 1.11–1.83, p trend = 0.03), dose–responsely negatively associated with LDL‐C levels over quartiles (HR Q2vs.Q1 = 0.83, 95% CI: 0.66–1.02; HR Q3vs.Q1 = 0.86, 95% CI: 0.69–1.07; HR Q4vs.Q1 = 0.68, 95% CI: 0.53–0.86, p trend = 0.02), and showed a diminished negative association with HDL‐C levels over quartiles (HR Q2vs.Q1 = 0.75, 95% CI: 0.60–0.94; HR Q3vs.Q1 = 0.76, 95% CI: 0.61–0.95; HR Q4vs.Q1 = 0.91, 95% CI 0.74–1.13, p trend = 0.02). The subsequent RCS analysis revealed a linear negative relationship of LDL‐C ( p overall = 0.004, p nonlinear = 0.67) and a U‐shaped relationship of HDL‐C ( p overall = 0.05, p nonlinear = 0.02) with CRC risk. Competitive risk analysis and sensitivity analysis confirmed the stability of our results.
Conclusion
We observed a U‐shaped relationship regarding HDL‐C levels with EC and CRC risk, and a linear inverse relationship between LDL‐C levels and CRC risk. Relevant serum lipid levels should be properly managed in high‐risk individuals of certain gastrointestinal cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing, China.
- Department of Cardiology, Kailuan General Hospital, Tangshan, China.
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Jiansong Yuan
Zitieren
APA
Xiao, Y., Du, X., Wang, T., Liu, D., You, H., Wang, H., Liang, H., Ba, Z., Liu, Y., Ren, Y., Zeng, J., Yang, W., Wu, S., & Yuan, J. (2025). Serum Lipid Biomarkers and the Risk of Gastrointestinal Cancers in a Chinese Population: The Kailuan Prospective Study. Cancer Medicine. https://doi.org/10.1002/cam4.70654
Vancouver
Xiao Y, Du X, Wang T, Liu D, You H, Wang H, et al. Serum Lipid Biomarkers and the Risk of Gastrointestinal Cancers in a Chinese Population: The Kailuan Prospective Study. Cancer Medicine. 2025. doi:10.1002/cam4.70654
BibTeX
@article{Xiao2025,
author = {Xiao, Ying and Du, Xin and Wang, Tianjie and Liu, Dong and You, Hongzhao and Wang, Hao and Liang, Hanyang and Ba, Zhengqing and Liu, Yilu and Ren, Yu and Zeng, Jinghan and Yang, Weixian and Wu, Shouling and Yuan, Jiansong},
title = {Serum Lipid Biomarkers and the Risk of Gastrointestinal Cancers in a Chinese Population: The Kailuan Prospective Study},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70654}
}
EUVIMED